Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2020-03-13 | ENZN | Enzon Pharmaceuticals, Inc. | Couchman Jonathan | 10% | P - Purchase | $0.14 | +652,723 | 7,345,162 | +10% | +$91,283 | |||||
| M | 2020-03-26 | BIEI | Premier Biomedical Inc | Felder Mitchell S | COB, 10% | P - Purchase | $0.00 | +5,000,000 | 18,334,488 | +37% | +$7,100 | |||||
2020-03-26 | STRO | Sutro Biopharma, Inc. | Hallam Trevor | Chief Science Officer | S - Sale | $9.69 | -975 | 21,665 | -4% | -$9,453 | ||||||
| M | 2020-03-25 | CASI | Casi Pharmaceuticals, Inc. | He Wei-Wu | COB, CEO, 10% | P - Purchase | $2.03 | +524,493 | 8,125,439 | +7% | +$1,066,731 | |||||
| M | 2020-03-13 | TCRR | Tcr2 Therapeutics Inc. | Gibson Neil W | Dir | S - Sale | $6.59 | -79,640 | 0 | -100% | -$525,188 | |||||
2020-03-24 | RGEN | Repligen Corp | Cox John | Dir | S - Sale | $96.72 | -1,858 | 923 | -67% | -$179,706 | ||||||
2020-03-24 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $2.90 | +1,200 | 171,911 | +1% | +$3,480 | ||||||
2020-03-24 | CSBR | Champions Oncology, Inc. | Mendelson Daniel Newman | Dir | P - Purchase | $5.50 | +26 | 57,526 | 0% | +$143 | ||||||
2020-03-24 | CSBR | Champions Oncology, Inc. | Morris Ronnie | CEO | S - Sale | $5.25 | -75 | 837,168 | 0% | -$394 | ||||||
2020-03-25 | APTO | Aptose Biosciences Inc. | Rice William G. | Chair, Pres, CEO | P - Purchase | $5.82 | +3,400 | 466,414 | +1% | +$19,803 | ||||||
2020-03-23 | PTE | Polarityte, Inc. | Mann Paul Elliot | CFO | S - Sale | $1.05 | -1,283 | 439,111 | 0% | -$1,347 | ||||||
2020-03-23 | PTE | Polarityte, Inc. | Hoyler Cameron J. | Gen. Counsel, EVP | S - Sale | $1.05 | -3,500 | 324,056 | -1% | -$3,675 | ||||||
2020-03-24 | PASG | Passage Bio, Inc. | Countouriotis Athena | Dir | P - Purchase | $14.97 | +10,000 | 18,900 | +112% | +$149,750 | ||||||
| M | 2020-03-23 | ALEC | Alector, Inc. | Orbimed Advisors LLC | 10% | S - Sale | $24.70 | -138,653 | 2,080,243 | -6% | -$3,425,269 | |||||
| M | 2020-03-24 | NTGN | Neon Therapeutics, Inc. | Access Industries Holdings LLC | 10% | S - Sale | $2.19 | -252,044 | 2,836,766 | -8% | -$552,802 | |||||
| D | 2020-03-20 | ADVM | Adverum Biotechnologies, Inc. | Patterson Leone D | CEO, Pres, Dir | S - Sale+OE | $10.17 | -39,526 | 123,429 | -24% | -$401,908 | |||||
| M | 2020-03-23 | MRNA | Moderna, Inc. | Hoge Stephen | Pres | S - Sale | $26.58 | -10,000 | 2,040,656 | 0% | -$265,812 | |||||
| D | 2020-03-23 | GILD | Gilead Sciences Inc | Cogan John Francis | Dir | S - Sale+OE | $75.27 | -2,413 | 54,860 | -4% | -$181,627 | |||||
2020-03-20 | KOD | Kodiak Sciences Inc. | Levy Richard S | Dir | P - Purchase | $44.33 | +1,000 | 1,000 | New | +$44,330 | ||||||
| D | 2020-03-20 | KOD | Kodiak Sciences Inc. | Ehrlich Jason | See Remarks | S - Sale+OE | $45.00 | -6,950 | 22,542 | -24% | -$312,762 | |||||
2020-03-20 | CSBR | Champions Oncology, Inc. | Morris Ronnie | CEO | P - Purchase | $4.75 | +75 | 837,243 | 0% | +$356 | ||||||
| M | 2020-03-20 | NTGN | Neon Therapeutics, Inc. | Access Industries Holdings LLC | 10% | S - Sale | $2.25 | -93,389 | 3,004,524 | -3% | -$209,664 | |||||
| A | 2019-09-24 | CDTX | Cidara Therapeutics, Inc. | Levine James E. | CFO | P - Purchase | $1.91 | +30,000 | 30,000 | New | +$57,240 | |||||
2020-03-19 | KOD | Kodiak Sciences Inc. | Liang Hong | SVP, Discovery Medicine | S - Sale | $39.45 | -4,000 | 138,166 | -3% | -$157,811 | ||||||
| DM | 2020-03-19 | ADPT | Adaptive Biotechnologies Corp | Robins Chad M | CEO, COB | S - Sale+OE | $22.50 | -16,680 | 2,728,180 | -1% | -$375,236 | |||||
2020-03-20 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $29.13 | -10,000 | 54,770 | -15% | -$291,300 | ||||||
2020-03-20 | MRNA | Moderna, Inc. | Bancel Stephane | CEO | S - Sale | $29.13 | -25,195 | 15,927,836 | 0% | -$733,930 | ||||||
2020-03-19 | ADMA | Adma Biologics, Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $2.10 | +500,000 | 16,584,802 | +3% | +$1,050,000 | ||||||
2020-03-19 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $2.95 | +400 | 170,711 | 0% | +$1,180 | ||||||
| D | 2020-03-19 | SGMO | Sangamo Therapeutics, Inc | Dilly Stephen George | Dir | S - Sale+OE | $6.00 | -35,000 | 5,000 | -88% | -$210,000 | |||||
| D | 2020-03-18 | RGEN | Repligen Corp | Cox John | Dir | S - Sale+OE | $95.27 | -26,736 | 2,781 | -91% | -$2,547,035 | |||||
2020-03-18 | SGMO | Sangamo Therapeutics, Inc | Parker H Stewart | Dir | P - Purchase | $5.20 | +3,000 | 13,000 | +30% | +$15,585 | ||||||
2020-03-19 | HALO | Halozyme Therapeutics, Inc. | Kelley Kenneth J | Dir | P - Purchase | $14.23 | +52,629 | 277,553 | +23% | +$748,697 | ||||||
2020-03-17 | RUBY | Rubius Therapeutics, Inc. | Epstein David R | Dir | P - Purchase | $3.76 | +5,000 | 4,815,453 | 0% | +$18,800 | ||||||
| M | 2020-03-17 | CASI | Casi Pharmaceuticals, Inc. | He Wei-Wu | COB, CEO, 10% | P - Purchase | $1.53 | +1,000,002 | 7,600,946 | +15% | +$1,526,444 | |||||
2020-03-17 | SGMO | Sangamo Therapeutics, Inc | Zakrzewski Joseph S | Dir | P - Purchase | $4.99 | +5,000 | 30,000 | +20% | +$24,950 | ||||||
| DM | 2020-03-17 | MRNA | Moderna, Inc. | Andres Juan | See remarks | S - Sale+OE | $31.25 | -31,598 | 0 | -100% | -$987,365 | |||||
| M | 2020-03-17 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $2.59 | +3,500 | 170,311 | +2% | +$9,081 | |||||
| D | 2020-03-16 | SGMO | Sangamo Therapeutics, Inc | Dilly Stephen George | Dir | S - Sale+OE | $6.02 | -15,000 | 5,000 | -75% | -$90,261 | |||||
| M | 2020-03-16 | KRYS | Krystal Biotech, Inc. | Krishnan Suma | COO, 10% | S - Sale | $40.49 | -15,398 | 3,984,688 | 0% | -$623,412 | |||||
2020-03-17 | ADVM | Adverum Biotechnologies, Inc. | Patterson Leone D | CEO, Pres, Dir | S - Sale | $10.02 | -474 | 138,531 | 0% | -$4,749 | ||||||
| M | 2020-03-16 | KOD | Kodiak Sciences Inc. | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $39.29 | +150,000 | 10,602,550 | +1% | +$5,893,804 | |||||
| DM | 2020-03-16 | HARP | Harpoon Therapeutics, Inc. | Sacks Natalie | Chief Medical Officer | S - Sale+OE | $12.00 | -1,521 | 45,754 | -3% | -$18,252 | |||||
| D | 2020-03-16 | RGEN | Repligen Corp | Ryan Thomas F Jr | Dir | S - Sale+OE | $91.48 | -1,000 | 1,923 | -34% | -$91,480 | |||||
2020-03-16 | MRNA | Moderna, Inc. | Kim Lorence H. | CFO | S - Sale | $26.19 | -20,000 | 1,242,510 | -2% | -$523,819 | ||||||
2020-03-16 | ALLO | Allogene Therapeutics, Inc. | Moore Alison | Chief Technical Officer | S - Sale | $19.19 | -3,750 | 63,021 | -6% | -$71,980 | ||||||
2020-03-16 | ALLO | Allogene Therapeutics, Inc. | Schmidt Eric Thomas | CFO | S - Sale | $19.73 | -5,450 | 1,275,501 | 0% | -$107,508 | ||||||
2020-03-16 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO | S - Sale | $19.31 | -20,335 | 3,406,824 | -1% | -$392,615 | ||||||
| D | 2020-03-16 | GILD | Gilead Sciences Inc | Cogan John Francis | Dir | S - Sale+OE | $67.26 | -2,413 | 54,860 | -4% | -$162,298 | |||||
2020-03-13 | ALEC | Alector, Inc. | Paul Robert | Chief Medical Officer | S - Sale | $22.93 | -10,000 | 253,719 | -4% | -$229,286 | ||||||
2020-03-13 | RUBY | Rubius Therapeutics, Inc. | Epstein David R | Dir | P - Purchase | $3.91 | +10,000 | 4,810,453 | 0% | +$39,100 | ||||||
2020-03-16 | EIGR | Eiger Biopharmaceuticals, Inc. | Dietz Thomas John | Dir | P - Purchase | $4.95 | +1,000 | 30,000 | +3% | +$4,950 | ||||||
2020-03-16 | EIGR | Eiger Biopharmaceuticals, Inc. | Glenn Jeffrey S | Dir | P - Purchase | $5.03 | +30,000 | 217,879 | +16% | +$150,813 | ||||||
2020-03-16 | ALDX | Aldeyra Therapeutics, Inc. | Douglas Richard | Dir | P - Purchase | $2.75 | +40,000 | 125,000 | +47% | +$110,000 | ||||||
2020-03-13 | MRNA | Moderna, Inc. | Bancel Stephane | CEO | S - Sale | $21.17 | -11,046 | 24,568,093 | 0% | -$233,857 | ||||||
2020-03-13 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $23.00 | -10,000 | 64,770 | -13% | -$230,000 | ||||||
| M | 2020-03-12 | MRNA | Moderna, Inc. | Hoge Stephen | Pres | S - Sale | $22.06 | -9,990 | 2,050,656 | 0% | -$220,366 | |||||
2020-03-12 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $3.15 | +3,400 | 166,811 | +2% | +$10,710 | ||||||
2020-03-13 | TCON | Tracon Pharmaceuticals, Inc. | Theuer Charles | Pres, CEO | P - Purchase | $1.13 | +4,100 | 50,877 | +9% | +$4,624 | ||||||
| M | 2020-03-12 | SGMO | Sangamo Therapeutics, Inc | Zakrzewski Joseph S | Dir | P - Purchase | $6.15 | +20,000 | 25,000 | +400% | +$123,000 | |||||
| AD | 2020-03-03 | PASG | Passage Bio, Inc. | Ratcliffe Liam | Dir | P - Purchase | $18.00 | +552,800 | 2,619,430 | +27% | +$9,950,400 | |||||
| D | 2020-03-10 | GILD | Gilead Sciences Inc | Pletcher Brett A | EVP,Corp Affairs, GC | S - Sale+OE | $75.55 | -2,950 | 14,644 | -17% | -$222,873 | |||||
| D | 2020-03-11 | BIIB | Biogen Inc. | Sherwin Stephen A | Dir | S - Sale+OE | $295.22 | -2,434 | 15,438 | -14% | -$718,574 | |||||
2019-05-13 | CRTX | Cortexyme, Inc. | Young Kevin | Dir | P - Purchase | $17.00 | +30,000 | 30,000 | New | +$510,000 | ||||||
2019-05-13 | CRTX | Cortexyme, Inc. | Ryan Una S | Dir | P - Purchase | $17.00 | +2,875 | 2,875 | New | +$48,875 | ||||||
2019-05-13 | CRTX | Cortexyme, Inc. | McLoughlin Margaret | Dir | P - Purchase | $17.00 | +550 | 550 | New | +$9,350 | ||||||
| M | 2020-03-11 | TCON | Tracon Pharmaceuticals, Inc. | Theuer Charles | Pres, CEO | P - Purchase | $1.43 | +20,000 | 46,777 | +75% | +$28,639 | |||||
| D | 2020-03-09 | SGEN | Seattle Genetics Inc /wa | Siegall Clay B | Pres, CEO | S - Sale+OE | $110.09 | -28,472 | 758,784 | -4% | -$3,134,578 | |||||
2020-03-09 | MRNA | Moderna, Inc. | Lee Jennifer Ling | Chief Accounting Officer | S - Sale | $27.33 | -361 | 4,419 | -8% | -$9,866 | ||||||
2020-03-10 | MRNA | Moderna, Inc. | Bancel Stephane | CEO | S - Sale | $25.71 | -16,468 | 16,646,546 | 0% | -$423,392 | ||||||
| DM | 2020-03-09 | ADPT | Adaptive Biotechnologies Corp | Cohen Chad M | CFO | S - Sale+OE | $24.58 | -15,000 | 1,000 | -94% | -$368,679 | |||||
| D | 2020-03-09 | MRNA | Moderna, Inc. | Andres Juan | See remarks | S - Sale+OE | $30.00 | -104 | 0 | -100% | -$3,120 | |||||
| D | 2020-03-09 | NSTG | Nanostring Technologies Inc | Gray R Bradley | Pres, CEO | S - Sale+OE | $31.62 | -42,049 | 56,624 | -43% | -$1,329,480 | |||||
| D | 2020-03-10 | NSTG | Nanostring Technologies Inc | Bailey K Thomas | CFO | S - Sale+OE | $31.47 | -7,917 | 0 | -100% | -$249,185 | |||||
| D | 2020-03-09 | GILD | Gilead Sciences Inc | Cogan John Francis | Dir | S - Sale+OE | $77.97 | -2,413 | 54,860 | -4% | -$188,142 | |||||
| D | 2020-03-06 | SGEN | Seattle Genetics Inc /wa | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $114.91 | -8,000 | 188,674 | -4% | -$919,292 | |||||
2020-03-10 | TCON | Tracon Pharmaceuticals, Inc. | Theuer Charles | Pres, CEO | P - Purchase | $1.87 | +10,000 | 26,777 | +60% | +$18,691 | ||||||
| D | 2020-03-06 | CSBR | Champions Oncology, Inc. | New Enterprise Associates 14, L.P. | 10% | S - Sale+OE | $6.99 | -708,155 | 1,713,720 | -29% | -$4,950,003 | |||||
2020-03-10 | MNTA | Momenta Pharmaceuticals Inc | Wheeler Craig A | Pres, CEO | S - Sale | $28.75 | -347 | 568,325 | 0% | -$9,976 | ||||||
2020-03-06 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $27.98 | -10,000 | 74,770 | -12% | -$279,800 | ||||||
2020-03-06 | MRNA | Moderna, Inc. | Bancel Stephane | CEO | S - Sale | $28.89 | -11,046 | 24,600,283 | 0% | -$319,102 | ||||||
| D | 2020-03-06 | MNTA | Momenta Pharmaceuticals Inc | Wheeler Craig A | Pres, CEO | S - Sale+OE | $28.51 | -37,228 | 568,672 | -6% | -$1,061,370 | |||||
| D | 2020-03-06 | MNTA | Momenta Pharmaceuticals Inc | Kwon Young | Chief Financial, Bus. Officer | S - Sale+OE | $28.96 | -7,356 | 138,836 | -5% | -$213,030 | |||||
| D | 2020-03-06 | MNTA | Momenta Pharmaceuticals Inc | Beltramello Jo Ann | Chief HR, Inf. Officer | S - Sale+OE | $29.00 | -7,310 | 50,515 | -13% | -$211,990 | |||||
| D | 2020-03-06 | MNTA | Momenta Pharmaceuticals Inc | Manning Anthony M. | Chief Scientific Officer | S - Sale+OE | $29.00 | -7,310 | 12,758 | -36% | -$211,990 | |||||
| D | 2020-03-06 | MNTA | Momenta Pharmaceuticals Inc | Carvajal Alejandra | GC | S - Sale+OE | $29.00 | -5,302 | 9,698 | -35% | -$153,758 | |||||
| D | 2020-03-06 | MNTA | Momenta Pharmaceuticals Inc | Fier Ian | Chief Mfg, Program Officer | S - Sale+OE | $29.00 | -7,310 | 7,690 | -49% | -$211,990 | |||||
| D | 2020-03-06 | MNTA | Momenta Pharmaceuticals Inc | Arroyo Santiago | SVP, Chief Medical Officer | S - Sale+OE | $28.97 | -7,356 | 27,220 | -21% | -$213,103 | |||||
2020-03-04 | MRNA | Moderna, Inc. | Kim Lorence H. | CFO | S - Sale | $27.71 | -20,000 | 1,262,510 | -2% | -$554,200 | ||||||
| D | 2020-03-04 | TECH | Bio-Techne Corp | Eansor Norman David | Pres-Protein Sciences | S - Sale+OE | $198.68 | -1,387 | 0 | -100% | -$275,569 | |||||
| M | 2020-03-03 | RGEN | Repligen Corp | Snodgres Jon | CFO | S - Sale | $89.58 | -1,655 | 36,127 | -4% | -$148,247 | |||||
| DM | 2020-03-03 | RGEN | Repligen Corp | Ryan Thomas F Jr | Dir | S - Sale+OE | $87.84 | -7,021 | 1,923 | -78% | -$616,708 | |||||
| M | 2020-03-03 | RGEN | Repligen Corp | Kuriyel Ralf | SVP, R, D | S - Sale | $90.40 | -3,005 | 26,524 | -10% | -$271,645 | |||||
| D | 2020-03-04 | RGEN | Repligen Corp | Cox John | Dir | S - Sale+OE | $93.39 | -10,000 | 2,781 | -78% | -$933,900 | |||||
| M | 2020-03-03 | RGEN | Repligen Corp | Hunt Anthony | CEO | S - Sale | $89.84 | -14,490 | 230,241 | -6% | -$1,301,793 | |||||
2020-03-03 | CHRS | Coherus Biosciences, Inc. | Wahlstrom Mats | Dir | S - Sale | $20.12 | -118,066 | 200,000 | -37% | -$2,375,409 | ||||||
2020-03-05 | SRNE | Sorrento Therapeutics, Inc. | Smith Robin L | Dir | P - Purchase | $2.27 | +40,000 | 60,000 | +200% | +$90,896 | ||||||
| D | 2020-03-02 | ORTX | Orchard Therapeutics Plc | Gaspar Bobby | See Remarks | S - Sale+OE | $13.00 | -4,921 | 352,319 | -1% | -$63,973 | |||||
2020-03-03 | PTE | Polarityte, Inc. | Seaburg David B | Pres | S - Sale | $1.34 | -5,450 | 367,251 | -1% | -$7,303 | ||||||
| D | 2020-03-02 | MRNA | Moderna, Inc. | Andres Juan | See remarks | S - Sale+OE | $30.12 | -3,001 | 0 | -100% | -$90,390 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |